{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380580240140100238.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Markus Wahrmann"}],"foaf:familyName":[{"@value":"Wahrmann"}],"foaf:givenName":[{"@value":"Markus"}]}],"career":[{"institution":{"notation":[{"@value":"Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360580240140100224","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1097/tp.0000000000003247"},{"@type":"URI","@value":"https://journals.lww.com/10.1097/TP.0000000000003247"}],"notation":[{"@value":"CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1097/tp.0000000000003247_WEU2UWo6O7VDLla3VNU83yJonpM"}]}